Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
Neurofilament ELISA validation.
Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease.
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Multiple Sclerosis: Methods and Protocols. Preface.
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
Systemic lupus erythematosus presented as extensive longitudinal myelitis.
Prevalence of epilepsy in a cohort of patients with multiple sclerosis.
Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart Review.
Hand grip fatigability in persons with multiple sclerosis according to hand dominance and disease progression.
Rad51 Activates Polyomavirus JC Early Transcription.
IV immunoglobulin confounds JC virus antibody serostatus determination.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Epstein-Barr virus persistence and reactivation in neuromyelitis optica.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »